A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System

Gemcitabine is an antineoplastic drug used in several forms of advanced pancreatic, lung, breast, ovarian, and bladder cancer. Common side effects include bone marrow suppression, fatigue, diarrhea, nausea, gastrointestinal upset, rash, alopecia, and stomatitis. Transient serum enzyme elevations cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Mascherona, Ilenia, Maggioli, Caterina, Biggiogero, Maira, Mora, Oreste, Marelli, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556098/
https://www.ncbi.nlm.nih.gov/pubmed/33083070
http://dx.doi.org/10.1155/2020/8812983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556098/
https://www.ncbi.nlm.nih.gov/pubmed/33083070
http://dx.doi.org/10.1155/2020/8812983

Ejemplares similares